| Aia1 |
Adjuvant induced arthritis QTL 1 |
joint integrity trait (VT:0010548)
|
| Aia2 |
Adjuvant induced arthritis QTL 2 |
joint integrity trait (VT:0010548)
|
| Aia3 |
Adjuvant induced arthritis QTL 3 |
joint integrity trait (VT:0010548)
|
| Aia4 |
Adjuvant induced arthritis QTL 4 |
joint integrity trait (VT:0010548)
|
| Apr1 |
Acute phase response QTL 1 |
orosomucoid 1 amount (VT:0010541)
|
| Apr2 |
Acute phase response QTL 2 |
blood murinoglobulin 1 amount (VT:0010597)
|
| Apr3 |
Acute phase response QTL 3 |
blood interleukin-6 amount (VT:0008595)
|
| Apr4 |
Acute phase response QTL 4 |
orosomucoid 1 amount (VT:0010541)
|
| Apr5 |
Acute phase response QTL 5 |
blood interleukin-6 amount (VT:0008595)
|
| Apr6 |
Acute phase response QTL 6 |
blood interleukin-6 amount (VT:0008595)
|
| Ciaa1 |
CIA Autoantibody QTL 1 |
blood autoantibody amount (VT:0003725)
|
| Ciaa2 |
CIA Autoantibody QTL 2 |
blood autoantibody amount (VT:0003725)
|
| Ciaa3 |
CIA Autoantibody QTL 3 |
blood autoantibody amount (VT:0003725)
|
| Eae1 |
Experimental allergic encephalomyelitis QTL 1 |
nervous system integrity trait (VT:0010566)
|
| Eae10 |
Experimental allergic encephalomyelitis QTL 10 |
nervous system integrity trait (VT:0010566)
|
| Eae11 |
Experimental allergic encephalomyelitis QTL 11 |
nervous system integrity trait (VT:0010566)
|
| Eae12 |
Experimental allergic encephalomyelitis QTL 12 |
nervous system integrity trait (VT:0010566)
|
| Eae13 |
Experimental allergic encephalomyelitis QTL 13 |
nervous system integrity trait (VT:0010566)
|
| Eae14 |
Experimental allergic encephalomyelitis QTL 14 |
nervous system integrity trait (VT:0010566)
|
| Eae15 |
Experimental allergic encephalomyelitis QTL 15 |
nervous system integrity trait (VT:0010566)
|
| Eae19 |
Experimental allergic encephalomyelitis QTL 19 |
nervous system integrity trait (VT:0010566)
|
| Eae20 |
Experimental allergic encephalomyelitis QTL 20 |
nervous system integrity trait (VT:0010566)
|
| Eae21 |
Experimental allergic encephalomyelitis QTL 21 |
body mass (VT:0001259)
|
| Eae22 |
Experimental allergic encephalomyelitis QTL 22 |
nervous system integrity trait (VT:0010566)
|
| Eae4 |
Experimental allergic encephalomyelitis QTL 4 |
nervous system integrity trait (VT:0010566)
|
| Eae5 |
Experimental allergic encephalomyelitis QTL 5 |
nervous system integrity trait (VT:0010566)
|
| Eae6 |
Experimental allergic encephalomyelitis QTL 6 |
body mass (VT:0001259)
|
| Eae7 |
Experimental allergic encephalomyelitis QTL 7 |
body mass (VT:0001259)
|
| Eae8 |
Experimental allergic encephalomyelitis QTL 8 |
nervous system integrity trait (VT:0010566)
|
| Eae9 |
Experimental allergic encephalomyelitis QTL 9 |
body mass (VT:0001259)
|
| Eaex |
Experimental allergic encephalomyelitis QTL x |
nervous system integrity trait (VT:0010566)
|
| Eaey |
Experimental allergic encephalomyelitis QTL y |
nervous system integrity trait (VT:0010566)
|
| Eaez |
Experimental allergic encephalomyelitis QTL z |
nervous system integrity trait (VT:0010566)
|
| Iddm16 |
Insulin dependent diabetes mellitus QTL 16 |
blood glucose amount (VT:0000188)
|
| Iddm4 |
Insulin dependent diabetes mellitus QTL 4 |
blood glucose amount (VT:0000188)
|
| Iddm5 |
Insulin dependent diabetes mellitus QTL 5 |
blood glucose amount (VT:0000188)
|
| Iddm6 |
Insulin dependent diabetes mellitus QTL 6 |
blood glucose amount (VT:0000188)
|
| Nka1 |
Natural killer alloreactivity QTL 1 |
natural killer cell cytolysis trait (VT:0005070)
|
| Oia2 |
Oil induced arthritis QTL 2 |
joint integrity trait (VT:0010548)
|
| Pia1 |
Pristane induced arthritis QTL 1 |
joint integrity trait (VT:0010548)
|
| Pia2 |
Pristane induced arthritis QTL 2 |
joint integrity trait (VT:0010548)
|
| Pia3 |
Pristane induced arthritis QTL 3 |
joint integrity trait (VT:0010548)
|
| Pia4 |
Pristane induced arthritis QTL 4 |
joint integrity trait (VT:0010548)
|
| Pia5 |
Pristane induced arthritis QTL 5 |
joint integrity trait (VT:0010548)
|
| Pia6 |
Pristane induced arthritis QTL 6 |
joint integrity trait (VT:0010548)
|
| Tcas10 |
Tongue tumor susceptibility QTL 10 |
tongue integrity trait (VT:0010553)
|
| Tcas11 |
Tongue tumor susceptibility QTL 11 |
tongue integrity trait (VT:0010553)
|
| Tcas2 |
Tongue tumor susceptibility QTL 2 |
tongue integrity trait (VT:0010553)
|
| Tcas3 |
Tongue tumor susceptibility QTL 3 |
tongue integrity trait (VT:0010553)
|
| Tcas4 |
Tongue tumor susceptibility QTL 4 |
tongue integrity trait (VT:0010553)
|
| Tcas5 |
Tongue tumor susceptibility QTL 5 |
tongue integrity trait (VT:0010553)
|
| Tcas6 |
Tongue tumor susceptibility QTL 6 |
tongue integrity trait (VT:0010553)
|
| Tcas8 |
Tongue tumor susceptibility QTL 8 |
tongue integrity trait (VT:0010553)
|
| Tcas9 |
Tongue tumor susceptibility QTL 9 |
tongue integrity trait (VT:0010553)
|